Manuscripts
October 4, 2021
Predicting cardiac adverse events in patients receiving immune checkpoint inhibitors: a machine learning approach
The Journal for ImmunoTherapy of Cancer
Heilbroner SP et al
October 18, 2021
The Friends of Cancer Research Real World Data (RWD) Collaboration Pilot 2.0: Methodological Recommendations from Oncology Case Studies
Clinical Pharmacology & Therapeutics
Rivera D et al
February 21, 2021
Challenges and Opportunities to Developing a Frailty Index Using Electronic Health Record Data
Journal of Geriatric Oncology
Levit L et al
August 10, 2022
Incidence of SARS-CoV-2 and subsequent mortality in a multi-site cohort of patients with cancer in the CancerLinQ Discovery database
JCO Oncology Practice
Ray E et al
June 3, 2022
Retrospective analysis of real-world management of EGFR-mutated advanced NSCLC, after first-line EGFR-TKI treatment: US treatment patterns, attrition, and survival data
Drugs - Real World Outcomes
Nieva J et al
November 17, 2020
Utilizing Data Visualization to Identify Survival and Treatment Differences Between Women With De Novo and Recurrent Metastatic Breast Cancer
Clinical Breast Cancer
Gilbert A et al
March 11, 2021
Identification of transgender people with cancer in electronic health records (EHR): Recommendations based on CancerLinQ observations
JCO Oncology Practice
Alpert AB et al
January 7, 2022
Quantitating and assessing interoperability between electronic health records
Journal of the American Medical Informatics Association
Bernstam E et al
January 5, 2022
The Chasm between Cancer Quality Measures and EHR Data Quality
JCO Clinical Cancer Informatics
Schorer A et al
Abstracts
May 7, 2023
Patient characteristics, treatment patterns, and factors of biomarker testing among patients with advanced non-small cell lung cancer (ANSCLC) in the US, 2012-2020
ISPOR 2023
Yang M et al
May 1, 2023
Association of clinical trial enrollment and mortality amongst patients with advanced prostate cancer
AUA Annual Meeting 2023
Pessoa RR et al
April 30, 2023
Variation of hormonal agent usage with postoperative radiation therapy: Results from a population based cohort of prostate cancer patients in community oncology practices
AUA Annual Meeting 2023
Pessoa RR et al
February 17, 2023
Real-world treatment patterns and sequencing in patients with locally advanced or metastatic urothelial cancer (la/mUC) in the US
ASCO Genitourinary Cancers Symposium 2023
Kearney M et al
December 12, 2022
Survival of patients with multiple myeloma diagnosed with second primary malignancies: An ASCO CancerLinQ analysis
ASH Annual Meeting & Exposition 2022
Cooper JD et al
December 11, 2022
Secondary primary malignancies (SPMs) in adolescent and young adults (AYAs) with multiple myeloma (MM): An ASCO CancerLinQ analysis
ASH Annual Meeting & Exposition 2022
Gibson SJ et al
December 10, 2022
Racial disparities in newly diagnosed hematological malignancies in the United States during the COVID-19 pandemic, January 2020 to March 2021
ASH Annual Meeting & Exposition 2022
Bhandari S et al
December 6, 2022
Real world treatment patterns of adjuvant endocrine therapy and ovarian suppression in premenopausal HR+/HER2+ breast cancer
San Antonio Breast Conference Symposium 2022
Sukumar JS et al
September 10, 2022
Demographics, clinical characteristics, treatment patterns and clinical outcomes of patients with stages I-III resected NSCLC without known EGFR mutations
European Society for Medical Oncology 2022
Altorki NK et al
